266 related articles for article (PubMed ID: 25275033)
1. Optimization of ultrasmall superparamagnetic iron oxide (P904)-enhanced magnetic resonance imaging of lymph nodes: initial experience in a mouse model.
Yoo RE; Cho HR; Choi SH; Won JK; Kim JH; Sohn CH
Anticancer Res; 2014 Oct; 34(10):5389-96. PubMed ID: 25275033
[TBL] [Abstract][Full Text] [Related]
2. Comparison of two different iron oxide-based contrast agents for discrimination of benign and malignant lymph nodes.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Invest Radiol; 2012 Sep; 47(9):511-5. PubMed ID: 22864375
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging diagnosis of metastatic lymph nodes in a rabbit model: efficacy of PJY10, a new ultrasmall superparamagnetic iron oxide agent, with monodisperse iron oxide core and multiple-interaction ligands.
Yoo RE; Choi SH; Cho HR; Jeon BS; Kwon E; Kim EG; Park J; Myeong WJ; Won JK; Lee YS; Kim JH; Park SW; Sohn CH
PLoS One; 2014; 9(9):e107583. PubMed ID: 25216040
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
[TBL] [Abstract][Full Text] [Related]
5. Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?
Froehlich JM; Triantafyllou M; Fleischmann A; Vermathen P; Thalmann GN; Thoeny HC
Contrast Media Mol Imaging; 2012; 7(3):346-55. PubMed ID: 22539405
[TBL] [Abstract][Full Text] [Related]
6. Axillary lymph node metastases in patients with breast carcinomas: assessment with nonenhanced versus uspio-enhanced MR imaging.
Memarsadeghi M; Riedl CC; Kaneider A; Galid A; Rudas M; Matzek W; Helbich TH
Radiology; 2006 Nov; 241(2):367-77. PubMed ID: 17057065
[TBL] [Abstract][Full Text] [Related]
7. [Lymph node image with ultrasmall superparamagnetic iron oxide and comparison with pathological result].
Xue HD; Lei J; Li Z; Wang DT; Zhou WX; Dai W; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):139-45. PubMed ID: 19507589
[TBL] [Abstract][Full Text] [Related]
8. Discrimination of benign and malignant lymph nodes at 7.0T compared to 1.5T magnetic resonance imaging using ultrasmall particles of iron oxide: a feasibility preclinical study.
Kinner S; Maderwald S; Albert J; Parohl N; Corot C; Robert P; Baba HA; Barkhausen J
Acad Radiol; 2013 Dec; 20(12):1604-9. PubMed ID: 24200489
[TBL] [Abstract][Full Text] [Related]
9. [Magnetic resonance enhancement features of inflammatory lymph nodes with ultrasmall superparamagnetic iron oxide in rabbit model].
Lei J; Xue HD; Li S; Li Z; Jin ZY
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Apr; 31(2):182-6. PubMed ID: 19507597
[TBL] [Abstract][Full Text] [Related]
10. Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.
Weissleder R; Elizondo G; Wittenberg J; Lee AS; Josephson L; Brady TJ
Radiology; 1990 May; 175(2):494-8. PubMed ID: 2326475
[TBL] [Abstract][Full Text] [Related]
11. Comparison of lymph node metastases assessment with the use of USPIO-enhanced MR imaging at 1.5 T versus 3.0 T in a rabbit model.
Choi SH; Kim KH; Moon WK; Kim HC; Cha JH; Paik JH; Chang KH
J Magn Reson Imaging; 2010 Jan; 31(1):134-41. PubMed ID: 20027581
[TBL] [Abstract][Full Text] [Related]
12. MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits.
Hamm B; Taupitz M; Hussmann P; Wagner S; Wolf KJ
AJR Am J Roentgenol; 1992 Jan; 158(1):183-90. PubMed ID: 1727343
[TBL] [Abstract][Full Text] [Related]
13. Lymph node metastasis: ultrasmall superparamagnetic iron oxide-enhanced MR imaging versus PET/CT in a rabbit model.
Choi SH; Moon WK; Hong JH; Son KR; Cho N; Kwon BJ; Lee JJ; Chung JK; Min HS; Park SH
Radiology; 2007 Jan; 242(1):137-43. PubMed ID: 17090719
[TBL] [Abstract][Full Text] [Related]
14. Preoperative diagnosis of lymph node metastases in gastric cancer by magnetic resonance imaging with ferumoxtran-10.
Tatsumi Y; Tanigawa N; Nishimura H; Nomura E; Mabuchi H; Matsuki M; Narabayashi I
Gastric Cancer; 2006; 9(2):120-8. PubMed ID: 16767368
[TBL] [Abstract][Full Text] [Related]
15. Lymph node metastases: safety and effectiveness of MR imaging with ultrasmall superparamagnetic iron oxide particles--initial clinical experience.
Bellin MF; Roy C; Kinkel K; Thoumas D; Zaim S; Vanel D; Tuchmann C; Richard F; Jacqmin D; Delcourt A; Challier E; Lebret T; Cluzel P
Radiology; 1998 Jun; 207(3):799-808. PubMed ID: 9609907
[TBL] [Abstract][Full Text] [Related]
16. Interstitial MR lymphography with iron oxide particles: results in tumor-free and VX2 tumor-bearing rabbits.
Taupitz M; Wagner S; Hamm B; Binder A; Pfefferer D
AJR Am J Roentgenol; 1993 Jul; 161(1):193-200. PubMed ID: 8517301
[TBL] [Abstract][Full Text] [Related]
17. [Comparison between Gd-DTPA-enhanced MRI and USPIO-enhanced MRI in diagnosing benign and metastatic cervical lymph nodes in rabbit models].
Feng Y; Zhang GX; Wang H; Hu YS; Wang XF; Zheng LF
Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):813-8. PubMed ID: 21223685
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of lymph node metastases of breast cancer using ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Harada T; Tanigawa N; Matsuki M; Nohara T; Narabayashi I
Eur J Radiol; 2007 Sep; 63(3):401-7. PubMed ID: 17398053
[TBL] [Abstract][Full Text] [Related]
19. Locally advanced rectal cancer: MR imaging for restaging after neoadjuvant radiation therapy with concomitant chemotherapy. Part II. What are the criteria to predict involved lymph nodes?
Lahaye MJ; Beets GL; Engelen SM; Kessels AG; de Bruïne AP; Kwee HW; van Engelshoven JM; van de Velde CJ; Beets-Tan RG
Radiology; 2009 Jul; 252(1):81-91. PubMed ID: 19403848
[TBL] [Abstract][Full Text] [Related]
20. In vivo identification of sentinel lymph nodes using MRI and size-controlled and monodispersed magnetite nanoparticles.
Iida S; Imai K; Matsuda S; Itano O; Hatakeyama M; Sakamoto S; Kokuryo D; Okabayashi K; Endo T; Ishii Y; Hasegawa H; Aoki I; Handa H; Kitagawa Y
J Magn Reson Imaging; 2013 Dec; 38(6):1346-55. PubMed ID: 23554026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
